Webinar On-Demand: Breaking Down the Hottest Topic in Pharmacy: Humira Biosimilars
Uncover what could happen with Humira and the biosimilar market in 2023 While biosimilars have existed for many years, the topic has been gaining some serious new attention as AbbVie’s Humira—the number one selling drug in the U.S.—no longer has exclusivity in the market. Will biosimilar competitors increase competition, lower drug costs and knock Humira […]
Webinar On-Demand: Breaking Down the Hottest Topic in Pharmacy: Humira Biosimilars Read More »
